BioCentury
ARTICLE | Company News

GNSC provides HAP technology to Janssen

November 27, 2000 8:00 AM UTC

Genaissance will provide its HAP technology platform to Jannssen Research Foundation and The R.W. Johnson Pharmaceutical Research Institute, both members of the Johnson & Johnson (JNJ) family. The HAP...